- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Infectious Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Infectious Disease Diagnostics market size is estimated to be worth US$ 3749.5 million in 2021 and is forecast to a readjusted size of USD 4972.4 million by 2028 with a CAGR of 4.1% during review period. Hepatitis C accounting for % of the Infectious Disease Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Molecular Diagnostic Technique segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Infectious Disease Diagnostics include Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, and BD, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Molecular Diagnostic Technique
Traditional Diagnostic Technique
Market segment by Application, can be divided into
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)
Market segment by players, this report covers
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Infectious Disease Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Infectious Disease Diagnostics, with revenue, gross margin and global market share of Infectious Disease Diagnostics from 2019 to 2022.
Chapter 3, the Infectious Disease Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Infectious Disease Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Infectious Disease Diagnostics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Infectious Disease Diagnostics
1.2 Classification of Infectious Disease Diagnostics by Type
1.2.1 Overview: Global Infectious Disease Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Infectious Disease Diagnostics Revenue Market Share by Type in 2021
1.2.3 Molecular Diagnostic Technique
1.2.4 Traditional Diagnostic Technique
1.3 Global Infectious Disease Diagnostics Market by Application
1.3.1 Overview: Global Infectious Disease Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hepatitis C
1.3.3 Hepatitis B
1.3.4 Tuberculosis (TB)
1.3.5 Acquired Immunodeficiency Syndrome (AIDS)
1.3.6 Human Papillomavirus (HPV)
1.3.7 Methicillin-resistant Staphylococcus Aureus (MRSA)
1.4 Global Infectious Disease Diagnostics Market Size & Forecast
1.5 Global Infectious Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Infectious Disease Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Infectious Disease Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Infectious Disease Diagnostics Market Drivers
1.6.2 Infectious Disease Diagnostics Market Restraints
1.6.3 Infectious Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Bio Mérieux SA
2.1.1 Bio Mérieux SA Details
2.1.2 Bio Mérieux SA Major Business
2.1.3 Bio Mérieux SA Infectious Disease Diagnostics Product and Solutions
2.1.4 Bio Mérieux SA Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Bio Mérieux SA Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
2.2.4 Roche Diagnostics Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
2.3.4 Abbott Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Thermo Fischer Scientific
2.4.1 Thermo Fischer Scientific Details
2.4.2 Thermo Fischer Scientific Major Business
2.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
2.4.4 Thermo Fischer Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Thermo Fischer Scientific Recent Developments and Future Plans
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Infectious Disease Diagnostics Product and Solutions
2.5.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BD Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
2.6.4 Bio-Rad Laboratories Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Infectious Disease Diagnostics Product and Solutions
2.7.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Abbott Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Infectious Disease Diagnostics Product and Solutions
2.8.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business
2.9.3 Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
2.9.4 Johnson and Johnson Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Johnson and Johnson Recent Developments and Future Plans
2.10 Guangzhou Wondfo Biotech Co.,Ltd.
2.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
2.11 Getein Biotech, Inc.
2.11.1 Getein Biotech, Inc. Details
2.11.2 Getein Biotech, Inc. Major Business
2.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
2.11.4 Getein Biotech, Inc. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Getein Biotech, Inc. Recent Developments and Future Plans
2.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
2.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Details
2.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
2.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
2.13 BGI Genomics Co.,Ltd.
2.13.1 BGI Genomics Co.,Ltd. Details
2.13.2 BGI Genomics Co.,Ltd. Major Business
2.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.13.4 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 BGI Genomics Co.,Ltd. Recent Developments and Future Plans
2.14 Maccura Biotechnology Co.,Ltd.
2.14.1 Maccura Biotechnology Co.,Ltd. Details
2.14.2 Maccura Biotechnology Co.,Ltd. Major Business
2.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.14.4 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
2.15 Daan Gene
2.15.1 Daan Gene Details
2.15.2 Daan Gene Major Business
2.15.3 Daan Gene Infectious Disease Diagnostics Product and Solutions
2.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Daan Gene Recent Developments and Future Plans
2.16 Beijing Strong Biotechnologies,Inc
2.16.1 Beijing Strong Biotechnologies,Inc Details
2.16.2 Beijing Strong Biotechnologies,Inc Major Business
2.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
2.16.4 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
2.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
2.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Details
2.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
2.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
2.18 Guangdong Hybribio Biotech Co.,Ltd.
2.18.1 Guangdong Hybribio Biotech Co.,Ltd. Details
2.18.2 Guangdong Hybribio Biotech Co.,Ltd. Major Business
2.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.18.4 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
2.19 Shanghai Runda Medical Technology Co.,Ltd.
2.19.1 Shanghai Runda Medical Technology Co.,Ltd. Details
2.19.2 Shanghai Runda Medical Technology Co.,Ltd. Major Business
2.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
2.19.4 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
2.20 Tellgen Corporation
2.20.1 Tellgen Corporation Details
2.20.2 Tellgen Corporation Major Business
2.20.3 Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
2.20.4 Tellgen Corporation Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Tellgen Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Infectious Disease Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Infectious Disease Diagnostics Players Market Share in 2021
3.2.2 Top 10 Infectious Disease Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Infectious Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Infectious Disease Diagnostics Mergers & Acquisitions
3.5 Infectious Disease Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Infectious Disease Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Infectious Disease Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Infectious Disease Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Infectious Disease Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Infectious Disease Diagnostics Revenue by Type (2017-2028)
6.2 North America Infectious Disease Diagnostics Revenue by Application (2017-2028)
6.3 North America Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Infectious Disease Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Infectious Disease Diagnostics Revenue by Type (2017-2028)
7.2 Europe Infectious Disease Diagnostics Revenue by Application (2017-2028)
7.3 Europe Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Infectious Disease Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Infectious Disease Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Infectious Disease Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Diagnostics Revenue by Region (2017-2028)
8.3.2 China Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Infectious Disease Diagnostics Revenue by Type (2017-2028)
9.2 South America Infectious Disease Diagnostics Revenue by Application (2017-2028)
9.3 South America Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Infectious Disease Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Infectious Disease Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Infectious Disease Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Infectious Disease Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Infectious Disease Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Infectious Disease Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Infectious Disease Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Infectious Disease Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Infectious Disease Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Bio Mérieux SA Corporate Information, Head Office, and Major Competitors
Table 7. Bio Mérieux SA Major Business
Table 8. Bio Mérieux SA Infectious Disease Diagnostics Product and Solutions
Table 9. Bio Mérieux SA Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Infectious Disease Diagnostics Product and Solutions
Table 13. Roche Diagnostics Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Infectious Disease Diagnostics Product and Solutions
Table 17. Abbott Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fischer Scientific Major Business
Table 20. Thermo Fischer Scientific Infectious Disease Diagnostics Product and Solutions
Table 21. Thermo Fischer Scientific Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BD Corporate Information, Head Office, and Major Competitors
Table 23. BD Major Business
Table 24. BD Infectious Disease Diagnostics Product and Solutions
Table 25. BD Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Laboratories Major Business
Table 28. Bio-Rad Laboratories Infectious Disease Diagnostics Product and Solutions
Table 29. Bio-Rad Laboratories Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Abbott Corporate Information, Head Office, and Major Competitors
Table 31. Abbott Major Business
Table 32. Abbott Infectious Disease Diagnostics Product and Solutions
Table 33. Abbott Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Danaher Corporate Information, Head Office, and Major Competitors
Table 35. Danaher Major Business
Table 36. Danaher Infectious Disease Diagnostics Product and Solutions
Table 37. Danaher Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 39. Johnson and Johnson Major Business
Table 40. Johnson and Johnson Infectious Disease Diagnostics Product and Solutions
Table 41. Johnson and Johnson Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Guangzhou Wondfo Biotech Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 44. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 45. Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Getein Biotech, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Getein Biotech, Inc. Major Business
Table 48. Getein Biotech, Inc. Infectious Disease Diagnostics Product and Solutions
Table 49. Getein Biotech, Inc. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 51. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Major Business
Table 52. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 53. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. BGI Genomics Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 55. BGI Genomics Co.,Ltd. Major Business
Table 56. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 57. BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Maccura Biotechnology Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 59. Maccura Biotechnology Co.,Ltd. Major Business
Table 60. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 61. Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Daan Gene Corporate Information, Head Office, and Major Competitors
Table 63. Daan Gene Major Business
Table 64. Daan Gene Infectious Disease Diagnostics Product and Solutions
Table 65. Daan Gene Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Beijing Strong Biotechnologies,Inc Corporate Information, Head Office, and Major Competitors
Table 67. Beijing Strong Biotechnologies,Inc Major Business
Table 68. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Product and Solutions
Table 69. Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Shanghai Kehua Bio-Engineering Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 71. Shanghai Kehua Bio-Engineering Co.,Ltd. Major Business
Table 72. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 73. Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Guangdong Hybribio Biotech Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 75. Guangdong Hybribio Biotech Co.,Ltd. Major Business
Table 76. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 77. Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Shanghai Runda Medical Technology Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 79. Shanghai Runda Medical Technology Co.,Ltd. Major Business
Table 80. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Product and Solutions
Table 81. Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Tellgen Corporation Corporate Information, Head Office, and Major Competitors
Table 83. Tellgen Corporation Major Business
Table 84. Tellgen Corporation Infectious Disease Diagnostics Product and Solutions
Table 85. Tellgen Corporation Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Global Infectious Disease Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 87. Global Infectious Disease Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 88. Breakdown of Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Infectious Disease Diagnostics Players Head Office, Products and Services Provided
Table 90. Infectious Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 91. Infectious Disease Diagnostics New Entrants and Expansion Plans
Table 92. Global Infectious Disease Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 93. Global Infectious Disease Diagnostics Revenue Share by Type (2017-2022)
Table 94. Global Infectious Disease Diagnostics Revenue Forecast by Type (2023-2028)
Table 95. Global Infectious Disease Diagnostics Revenue by Application (2017-2022)
Table 96. Global Infectious Disease Diagnostics Revenue Forecast by Application (2023-2028)
Table 97. North America Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 98. North America Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 99. North America Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 100. North America Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 101. North America Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 102. North America Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 103. Europe Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 104. Europe Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 105. Europe Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 106. Europe Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 107. Europe Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 108. Europe Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 109. Asia-Pacific Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 110. Asia-Pacific Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 111. Asia-Pacific Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 112. Asia-Pacific Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 113. Asia-Pacific Infectious Disease Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 114. Asia-Pacific Infectious Disease Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 115. South America Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 116. South America Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 117. South America Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 118. South America Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 119. South America Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 120. South America Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 121. Middle East & Africa Infectious Disease Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 122. Middle East & Africa Infectious Disease Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 123. Middle East & Africa Infectious Disease Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 124. Middle East & Africa Infectious Disease Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 125. Middle East & Africa Infectious Disease Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 126. Middle East & Africa Infectious Disease Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. Global Infectious Disease Diagnostics Revenue Market Share by Type in 2021
Figure 3. Molecular Diagnostic Technique
Figure 4. Traditional Diagnostic Technique
Figure 5. Infectious Disease Diagnostics Revenue Market Share by Application in 2021
Figure 6. Hepatitis C Picture
Figure 7. Hepatitis B Picture
Figure 8. Tuberculosis (TB) Picture
Figure 9. Acquired Immunodeficiency Syndrome (AIDS) Picture
Figure 10. Human Papillomavirus (HPV) Picture
Figure 11. Methicillin-resistant Staphylococcus Aureus (MRSA) Picture
Figure 12. Global Infectious Disease Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Infectious Disease Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028)
Figure 15. Global Infectious Disease Diagnostics Revenue Market Share by Region in 2021
Figure 16. North America Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Infectious Disease Diagnostics Market Drivers
Figure 22. Infectious Disease Diagnostics Market Restraints
Figure 23. Infectious Disease Diagnostics Market Trends
Figure 24. Bio Mérieux SA Recent Developments and Future Plans
Figure 25. Roche Diagnostics Recent Developments and Future Plans
Figure 26. Abbott Laboratories Recent Developments and Future Plans
Figure 27. Thermo Fischer Scientific Recent Developments and Future Plans
Figure 28. BD Recent Developments and Future Plans
Figure 29. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 30. Abbott Recent Developments and Future Plans
Figure 31. Danaher Recent Developments and Future Plans
Figure 32. Johnson and Johnson Recent Developments and Future Plans
Figure 33. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments and Future Plans
Figure 34. Getein Biotech, Inc. Recent Developments and Future Plans
Figure 35. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments and Future Plans
Figure 36. BGI Genomics Co.,Ltd. Recent Developments and Future Plans
Figure 37. Maccura Biotechnology Co.,Ltd. Recent Developments and Future Plans
Figure 38. Daan Gene Recent Developments and Future Plans
Figure 39. Beijing Strong Biotechnologies,Inc Recent Developments and Future Plans
Figure 40. Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments and Future Plans
Figure 41. Guangdong Hybribio Biotech Co.,Ltd. Recent Developments and Future Plans
Figure 42. Shanghai Runda Medical Technology Co.,Ltd. Recent Developments and Future Plans
Figure 43. Tellgen Corporation Recent Developments and Future Plans
Figure 44. Global Infectious Disease Diagnostics Revenue Share by Players in 2021
Figure 45. Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 46. Global Top 3 Players Infectious Disease Diagnostics Revenue Market Share in 2021
Figure 47. Global Top 10 Players Infectious Disease Diagnostics Revenue Market Share in 2021
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 49. Global Infectious Disease Diagnostics Revenue Share by Type in 2021
Figure 50. Global Infectious Disease Diagnostics Market Share Forecast by Type (2023-2028)
Figure 51. Global Infectious Disease Diagnostics Revenue Share by Application in 2021
Figure 52. Global Infectious Disease Diagnostics Market Share Forecast by Application (2023-2028)
Figure 53. North America Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 54. North America Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 55. North America Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 56. United States Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Canada Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Mexico Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Europe Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 60. Europe Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 61. Europe Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 62. Germany Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. France Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. United Kingdom Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Russia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Italy Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Asia-Pacific Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 68. Asia-Pacific Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 69. Asia-Pacific Infectious Disease Diagnostics Revenue Market Share by Region (2017-2028)
Figure 70. China Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Japan Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Korea Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. India Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Southeast Asia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Australia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South America Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 77. South America Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 78. South America Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 79. Brazil Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Argentina Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Middle East and Africa Infectious Disease Diagnostics Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Infectious Disease Diagnostics Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Infectious Disease Diagnostics Revenue Market Share by Country (2017-2028)
Figure 84. Turkey Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Saudi Arabia Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. UAE Infectious Disease Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
